Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML)
Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if a single dose of pegfilgrastim is able to reduce
the time of severe neutropenia in patients receiving induction and consolidation
myelosuppressive chemotherapy for de novo acute myeloid leukemia similar to filgrastim.